Acad Emerg Med
- HOFFMANN JA, Carter CP, Olsen CS, Ashby D, et al
Pediatric mental health emergency department visits from 2017 to 2022: A
multicenter study.
Acad Emerg Med. 2024 Apr 2. doi: 10.1111/acem.14910.
Am J Obstet Gynecol
- GABBY LC, Jones CK, McIntyre BB, Manalo Z, et al
Chronic Villitis as a Distinctive Feature of Placental Injury in Maternal
SARS-CoV-2 Infection.
Am J Obstet Gynecol. 2024 Apr 3:S0002-9378(24)00480.
Am J Respir Crit Care Med
- CURLEY GF, O'Kane CM, McAuley DF, Matthay MA, et al
Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?
Am J Respir Crit Care Med. 2024;209:789-797.
Ann Intern Med
- GOTUR D, Mylonakis E
In adults with post-COVID-19 conditions, a synbiotic preparation, SIM01,
alleviated some symptoms at 6 mo.
Ann Intern Med. 2024 Apr 2. doi: 10.7326/J24-0018.
Antiviral Res
- SINIAVIN AE, Gushchin VA, Shastina NS, Darnotuk ES, et al
New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in
vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses.
Antiviral Res. 2024 Mar 28:105871. doi: 10.1016/j.antiviral.2024.105871.
- KHATUA K, Alugubelli YR, Yang KS, Vulupala VR, et al
Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors.
Antiviral Res. 2024;225:105874.
BMJ
- FONG KJ, Summers C, Cook TM
NHS hospital capacity during covid-19: overstretched staff, space, systems, and
stuff.
BMJ. 2024;385:e075613.
Clin Infect Dis
- TERZIC V, Miantezila Basilua J, Billard N, de Gastines L, et al
Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus
Disease 2019 (COVID-19): A Post Hoc Safety Analysis of the Randomized DisCoVeRy
Trial.
Clin Infect Dis. 2024 Mar 29:ciae170. doi: 10.1093.
- BIERE-RAFI S, Janssen K, Jurgens E, Kooij S, et al
Is Cognitive Behavioural Therapy Effective for Post-COVID Fatigue?
Clin Infect Dis. 2023;77:1074-1075.
- GOTTLIEB RL, Kalil AC
True DisCoVeRy of COVID-19 Disease Burden Versus Speculated Antiviral
Cardiovascular Risk Requires a Control Group.
Clin Infect Dis. 2024 Mar 29:ciae172. doi: 10.1093.
Emerg Infect Dis
- TUNSTALL AM, O'Brien SC, Monaghan DM, Burakoff A, et al
Lessons Learned from Cross-Systems Approach to COVID-19 Pandemic Response in
Juvenile Justice System, Colorado, USA.
Emerg Infect Dis. 2024;30:S13-S16.
- WADDELL C, Meehan A, Schoonveld M, Kaplan Z, et al
Lessons Learned from COVID-19 Response in Correctional and Detention Facilities.
Emerg Infect Dis. 2024;30:S5-S12.
- GURREY SO, Strick LB, Dov LK, Miller JS, et al
Lessons Learned from Public Health and State Prison Collaborations during
COVID-19 Pandemic and Multifacility Tuberculosis Outbreak, Washington, USA.
Emerg Infect Dis. 2024;30:S17-S20.
- HAGAN LM, Mosites E, Hughes-Baker L, Butler J, et al
Carceral Health is Public Health.
Emerg Infect Dis. 2024;30:S1-S4.
- SABER LB, Kennedy SS, Yang Y, Moore KN, et al
Correlation of SARS-CoV-2 in Wastewater and Individual Testing Results in a Jail,
Atlanta, Georgia, USA.
Emerg Infect Dis. 2024;30:S21-S27.
- PORTER LJ, Rapheal E, Huebsch R, Bastian T, et al
Development and Evaluation of Surveillance System for Identifying Jail-Associated
COVID-19 Cases in Minnesota, USA, 2022.
Emerg Infect Dis. 2024;30:S28-S35.
- KENDIG NE, Bur S, Zaslavsky J
Infection Prevention and Control in Correctional Settings.
Emerg Infect Dis. 2024;30:S88-S93.
Infect Control Hosp Epidemiol
- LEIS JA, Chan CK, Tan C, Callahan J, et al
Predictors of SARS-CoV-2 transmission in congregate living settings: a
multicenter prospective study.
Infect Control Hosp Epidemiol. 2024 Apr 2:1-6. doi: 10.1017/ice.2024.
Int J Infect Dis
- CORRECHER-MARTINEZ E, Lopez-Lacort M, Munoz-Quiles C, Diez-Domingo J, et al
Risk of herpes zoster in adults with SARS-CoV-2 infection in Spain: a
population-based, retrospective cohort study.
Int J Infect Dis. 2024 Apr 2:107037. doi: 10.1016/j.ijid.2024.107037.
- SALVADORI N, Jourdain G, Krittayaphong R, Siripongboonsitti T, et al
Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: a
randomized controlled trial in Thailand.
Int J Infect Dis. 2024 Mar 30:107021. doi: 10.1016/j.ijid.2024.107021.
J Infect
- COLSON P, Chaudet H, Delerce J, Pontarotti P, et al
Role of SARS-CoV-2 mutations in the evolution of the COVID-19 pandemic.
J Infect. 2024 Apr 1:106150. doi: 10.1016/j.jinf.2024.106150.
- NG M, S D, L W, R B, et al
Paediatric meningitis in the conjugate vaccine era and a novel clinical decision
model to predict bacterial aetiology.
J Infect. 2024 Mar 27:106145. doi: 10.1016/j.jinf.2024.106145.
J Med Virol
- HUNG KC, Yu TS, Wang KF, Chen IW, et al
Influenza vaccination on SARS-CoV-2 infection risk: A subgroup analysis on
geographic factor.
J Med Virol. 2024;96:e29576.
- FAN Y, Huang S, Wu D, Chu M, et al
Immune features revealed by single-cell RNA and single-cell TCR/BCR sequencing in
patients with rheumatoid arthritis receiving COVID-19 booster vaccination.
J Med Virol. 2024;96:e29573.
- MELE D, Ottolini S, Lombardi A, Conteianni D, et al
Long-term dynamics of natural killer cells in response to SARS-CoV-2 vaccination:
Persistently enhanced activity postvaccination.
J Med Virol. 2024;96:e29585.
- YANG H, Guan L, Yang T, Ma H, et al
Two- and 3-year outcomes in convalescent individuals with COVID-19: A prospective
cohort study.
J Med Virol. 2024;96:e29566.
- GANDIKOTA C, Vaddadi K, Sivasami P, Huang C, et al
The use of human iPSC-derived alveolar organoids to explore SARS-CoV-2 variant
infections and host responses.
J Med Virol. 2024;96:e29579.
- WOO HG, Kim HJ, Park J, Lee J, et al
Global burden of vaccine-associated multiple sclerosis, 1967-2022: A
comprehensive analysis of the international pharmacovigilance database.
J Med Virol. 2024;96:e29591.
- HE S, Liu SQ, Teng XY, He JY, et al
Comparative single-cell RNA sequencing analysis of immune response to inactivated
vaccine and natural SARS-CoV-2 infection.
J Med Virol. 2024;96:e29577.
- GUNGOR K, Bukavaz S, Ekuklu G
Measles outbreak in the adult age group: Clinical, laboratory, and
epidemiological features of the 11 patients admitted to the hospital.
J Med Virol. 2024;96:e29583.
J Virol
- ZHU Z, Han Y, Gong M, Sun B, et al
Establishment of replication-competent vesicular stomatitis virus recapitulating
SADS-CoV entry.
J Virol. 2024 Apr 1:e0195723. doi: 10.1128/jvi.01957.
- NAMBULLI S, Escriou N, Rennick LJ, Demers MJ, et al
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2
spike protein brought to phase I/II clinical trials: protection of African green
monkeys from COVID-19 disease.
J Virol. 2024 Apr 2:e0176223. doi: 10.1128/jvi.01762.
- BRUNET J, Choucha Z, Gransagne M, Tabbal H, et al
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2
spike protein brought to phase I/II clinical trials: candidate selection in a
preclinical murine model.
J Virol. 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693.
- XIAO X, Fu Y, You W, Huang C, et al
Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS
and abrogated by ORF7b-homologous interfering peptide.
J Virol. 2024 Apr 4:e0157323. doi: 10.1128/jvi.01573.
JAMA
- ANDERER S
Study: 1 of Every 9 US Cancer Cases Missed During 2020 Pandemic.
JAMA. 2024;331:1082.
- GUSSIN GM, McKinnell JA, Singh RD, Miller LG, et al
Reducing Hospitalizations and Multidrug-Resistant Organisms via Regional
Decolonization in Hospitals and Nursing Homes.
JAMA. 2024 Apr 1:e242759. doi: 10.1001/jama.2024.2759.
Lancet
- KULKARNI PS, Potey AV, Bharati S, Kunhihitlu A, et al
The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella
enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised,
active-controlled, double-blind trial.
Lancet. 2024 Mar 28:S0140-6736(24)00249-6. doi: 10.1016/S0140-6736(24)00249.
Lancet Infect Dis
- LARIVIERE Y, Matuvanga TZ, Osang'ir BI, Milolo S, et al
Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV
booster at 1 year versus 2 years in health-care and front-line workers in the
Democratic Republic of the Congo: secondary and exploratory outcomes of an
open-label, randomised
Lancet Infect Dis. 2024 Mar 26:S1473-3099(24)00058.
MMWR Morb Mortal Wkly Rep
- EL KALACH R, Jones-Jack N, Elam MA, Olorukooba A, et al
Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19
Vaccinations Across Sociodemographic Characteristics - United States, September
1, 2022-September 30, 2023.
MMWR Morb Mortal Wkly Rep. 2024;73:286-290.
Nature
- BARNES CO, Jette CA, Abernathy ME, Dam KA, et al
Author Correction: SARS-CoV-2 neutralizing antibody structures inform therapeutic
strategies.
Nature. 2024 Apr 2. doi: 10.1038/s41586-024-07344.
- FAIRBANK R
Long COVID still has no cure - so these patients are turning to research.
Nature. 2024;628:26-28.
- KANG Y, Hepojoki J, Maldonado RS, Mito T, et al
Ancestral allele of DNA polymerase gamma modifies antiviral tolerance.
Nature. 2024 Apr 3. doi: 10.1038/s41586-024-07260.
Radiol Imaging Cancer
- SPRAGUE BL, Nowak SA, Ahern TP, Herschorn SD, et al
Long-term Mammography Screening Trends and Predictors of Return to Screening
after the COVID-19 Pandemic: Results from a Statewide Registry.
Radiol Imaging Cancer. 2024;6:e230161.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016